David Baram – co-founder and CEO of Emendo Biotherapeutics

In this episode of Life Science Success, my guest is David Baram.  David Baram is the co-founder and CEO of Emendo Biotherapeutics. David has taken Emendo from the pre-seed stage through multiple financing rounds and a successful acquisition in 2020.

  • Don Davis, PhD, MBA interviews David Baram, PhD, CEO of Emendo Biotherapeautics
  • Mendo is focused on developing gene editing therapies for rare and prevalent diseases, including cardiovascular diseases.
  • They discuss the challenges of managing a company with different interests at play, including investors and patients.
  • They touch on the potential of AI and the need for regulation and control.
  • David shares his motivation and excitement in achieving his goals and seeing his inventions materialize.

Subscribe

Pitch Deck Pro AI

Telling Your Story Can Be Challenging

With minimal details, our pitchdeck pro tool will help you lay out the slides and the message that is needed to tell your story in the most effective way.